标题
Activated PI3 Kinase Delta Syndrome: From Genetics to Therapy
作者
关键词
-
出版物
Frontiers in Immunology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-02-27
DOI
10.3389/fimmu.2018.00369
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mutations in the adaptor-binding domain and associated linker region of p110δ cause Activated PI3K-δ Syndrome 1 (APDS1)
- (2017) Lucie Heurtier et al. HAEMATOLOGICA
- Novel PIK3CD mutations affecting N-terminal residues of p110δ cause activated PI3Kδ syndrome (APDS) in humans
- (2017) Andrew J. Takeda et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study
- (2017) Tanya I. Coulter et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CD
- (2017) Alina E. Dulau Florea et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies
- (2017) Aziz Bousfiha et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Conformational disruption of PI3Kδ regulation by immunodeficiency mutations inPIK3CDandPIK3R1
- (2017) Gillian L. Dornan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety, pharmacokinetics and dose-response characteristics of GSK2269557, an inhaled PI3Kδ inhibitor under development for the treatment of COPD
- (2017) A. Cahn et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors
- (2017) Klemens Hoegenauer et al. ACS Medicinal Chemistry Letters
- Mutations in the adaptor-binding domain and associated linker region of p110δ cause Activated PI3K-δ Syndrome 1 (APDS1)
- (2017) Lucie Heurtier et al. HAEMATOLOGICA
- Phosphatase and tensin homolog ( PTEN ) mutation can cause activated phosphatidylinositol 3-kinase δ syndrome–like immunodeficiency
- (2016) Yuki Tsujita et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study
- (2016) Elodie Elkaim et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Analysis of protein-coding genetic variation in 60,706 humans
- (2016) Monkol Lek et al. NATURE
- Activating PI3Kδ mutations in a cohort of 669 patients with primary immunodeficiency
- (2015) M. Elgizouli et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease
- (2015) Kenneth Down et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synergy in activating class I PI3Ks
- (2015) John E. Burke et al. TRENDS IN BIOCHEMICAL SCIENCES
- Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndrome
- (2014) Sven Kracker et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mutations in PIK3CD Can Cause Hyper IgM Syndrome (HIGM) Associated with Increased Cancer Susceptibility
- (2014) M. C. Crank et al. JOURNAL OF CLINICAL IMMUNOLOGY
- A human immunodeficiency caused by mutations in the PIK3R1 gene
- (2014) Marie-Céline Deau et al. JOURNAL OF CLINICAL INVESTIGATION
- Heterozygous splice mutation inPIK3R1causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K
- (2014) Carrie L. Lucas et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PI3K and cancer: lessons, challenges and opportunities
- (2014) David A. Fruman et al. NATURE REVIEWS DRUG DISCOVERY
- PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
- (2014) Ajay K. Gopal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- PIK3R1 Mutations Cause Syndromic Insulin Resistance with Lipoatrophy
- (2013) Christel Thauvin-Robinet et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Mutations in PIK3R1 Cause SHORT Syndrome
- (2013) David A. Dyment et al. AMERICAN JOURNAL OF HUMAN GENETICS
- SHORT Syndrome with Partial Lipodystrophy Due to Impaired Phosphatidylinositol 3 Kinase Signaling
- (2013) Kishan Kumar Chudasama et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseases
- (2013) Srividya Sriskantharajah et al. Annals of the New York Academy of Sciences
- Signaling by the Phosphoinositide 3-Kinase Family in Immune Cells
- (2013) Klaus Okkenhaug Annual Review of Immunology
- Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency
- (2013) Carrie L Lucas et al. NATURE IMMUNOLOGY
- Phosphoinositide 3-Kinase Gene Mutation Predisposes to Respiratory Infection and Airway Damage
- (2013) I. Angulo et al. SCIENCE
- PI3 Kinase δ Is a Key Regulator of Synoviocyte Function in Rheumatoid Arthritis
- (2012) Beatrix Bartok et al. AMERICAN JOURNAL OF PATHOLOGY
- Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K
- (2012) Mary Ellen Conley et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110 (PIK3CA)
- (2012) J. E. Burke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A frequent kinase domain mutation that changes the interaction between PI3K and the membrane
- (2009) D. Mandelker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More